Overview

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in North America. The purpose of this study is to determine if Vagifem Low Dose is an effective and safe treatment for patients suffering from postmenopausal atrophic vaginitis.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate